The Vanderbilt Maternal Addiction Recovery Program is participating in a 12-site clinical trial that will compare two forms of the medication buprenorphine in treating opioid use disorder during pregnancy, and the results could have a potentially significant impact on clinical practice.

Vanderbilt’s Department of Obstetrics and Gynecology (OB-GYN) was recently awarded a $200,000 grant by the Tennessee Department of Mental Health and Substance Abuse Services (TDMHSAS) to provide increased access to medication-assisted treatment for uninsured women with substance use disorders.

Renewal House and Vanderbilt University Medical Center (VUMC) have launched an alliance that will expedite treatment and expand the community’s capacity to treat mothers and children most acutely affected by opioid addiction in the mid-state.